These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats]. Kakusaka I; Kaneko N; Kiyatake K; Fujita A; Suzuki A; Nakano K; Okada O; Sugita T; Watanabe S; Kuriyama T Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):51-6. PubMed ID: 2501548 [TBL] [Abstract][Full Text] [Related]
4. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy. Langleben D; Reid LM Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262 [TBL] [Abstract][Full Text] [Related]
5. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats. Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069 [TBL] [Abstract][Full Text] [Related]
6. Improvement of mortality by long-term E4010 treatment in monocrotaline-induced pulmonary hypertensive rats. Kodama K; Adachi H J Pharmacol Exp Ther; 1999 Aug; 290(2):748-52. PubMed ID: 10411587 [TBL] [Abstract][Full Text] [Related]
8. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats. Gur S; Kadowitz PJ; Thammasitboon S; Lasky JA; Hellstrom WJ J Androl; 2009; 30(5):495-504. PubMed ID: 19201699 [TBL] [Abstract][Full Text] [Related]
9. Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease. Pan LC; Wilson DW; Segall HJ Toxicology; 1993 Mar; 79(1):21-35. PubMed ID: 8475497 [TBL] [Abstract][Full Text] [Related]
10. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension. Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y Respiration; 2006; 73(1):105-12. PubMed ID: 16432296 [TBL] [Abstract][Full Text] [Related]
11. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension]. Tabata T; Ono S; Song C; Noda M; Suzuki S; Tanita T; Fujimura S Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):160-6. PubMed ID: 9103852 [TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats. Mathew R; Zeballos GA; Tun H; Gewitz MH Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621 [TBL] [Abstract][Full Text] [Related]
13. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension]. Ono S; Tanita T; Hoshikawa Y; Song C; Maeda S; Tabata T; Noda M; Ueda S; Ashino Y; Fujimura S Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567 [TBL] [Abstract][Full Text] [Related]
14. Aspirin attenuates pulmonary arterial hypertension in rats by reducing plasma 5-hydroxytryptamine levels. Shen L; Shen J; Pu J; He B Cell Biochem Biophys; 2011 Sep; 61(1):23-31. PubMed ID: 21327581 [TBL] [Abstract][Full Text] [Related]
15. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204 [TBL] [Abstract][Full Text] [Related]
16. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats. Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320 [TBL] [Abstract][Full Text] [Related]
17. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension. Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912 [TBL] [Abstract][Full Text] [Related]
18. Suppressive effect of pulmonary hypertension and leukocyte activation by inhaled prostaglandin E1 in rats with monocrotaline-induced pulmonary hypertension. Kato S; Sugimura H; Kishiro I; Machida M; Suzuki H; Kaneko N Exp Lung Res; 2002 Jun; 28(4):265-73. PubMed ID: 12042029 [TBL] [Abstract][Full Text] [Related]
19. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)]. Ono S; Tanita T; Ashino Y; Noda M; Tabata S; Hoshikawa Y; Ueda S; Nishimura T; Fujimura S Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May; 32(5):441-5. PubMed ID: 8084100 [TBL] [Abstract][Full Text] [Related]
20. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline. Shubat PJ; Hubbard AK; Huxtable RJ J Toxicol Environ Health; 1989; 28(4):445-60. PubMed ID: 2531804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]